<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="9296">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05701020</url>
  </required_header>
  <id_info>
    <org_study_id>PI2019_843_0105</org_study_id>
    <nct_id>NCT05701020</nct_id>
  </id_info>
  <brief_title>Evaluation of Prevalence of Sexuality Alteration in Women With an Abnormal Pap Test</brief_title>
  <acronym>EVASEF</acronym>
  <official_title>Evaluation of Prevalence of Sexuality Alteration in Women With an Abnormal Pap Test</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Human Papilloma virus is the most common sexual infection in women, which can leads to&#xD;
      cervical lesion and cervical cancer. Pap test is recommanded in women of 25 years old until&#xD;
      65 years old in order to screen subclinic lesions and improve prognosis. Yet, scientific&#xD;
      knowledge about chronic disease showed negative consequences on quality of life.&#xD;
&#xD;
      However, no study until now has striven to evaluate the consequences of an abnormal pap test&#xD;
      on sexuality in adult women. The aim of this study is to evaluate if an abnormal pap test&#xD;
      have an impact on the sexual functions in women because of the anxiety and psychological&#xD;
      consequences of the diagnosis&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 13, 2022</start_date>
  <completion_date type="Anticipated">June 2024</completion_date>
  <primary_completion_date type="Anticipated">December 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>% ofpositive response rate at the first question of the questionnaire</measure>
    <time_frame>18 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of causes of woman alteration sexual function alteration</measure>
    <time_frame>18 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Sexual Dysfunction</condition>
  <condition>Epidemiology</condition>
  <arm_group>
    <arm_group_label>Adult women with an abnormal pap test</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>questionnary</intervention_name>
    <description>If agreeing to the protocol, ; patients will answered questions about sexual health during the gynecologic consultation</description>
    <arm_group_label>Adult women with an abnormal pap test</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult women with an abnormal pap test.&#xD;
&#xD;
          -  Diagnosis known 4 to 12 weeks before the appointment for colposcopy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cervical cancer&#xD;
&#xD;
          -  Pregnancy&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Adult women with an abnormal pap test</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Arthur Foulon, MD</last_name>
    <phone>03 22 08 80 51</phone>
    <email>foulon.arthur@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80480</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arthur Foulon, MD</last_name>
      <phone>(33)3 22 66 88 20</phone>
      <email>foulon.arthur@chu-amiens.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2022</verification_date>
  <study_first_submitted>January 10, 2023</study_first_submitted>
  <study_first_submitted_qc>January 24, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">January 27, 2023</study_first_posted>
  <last_update_submitted>January 24, 2023</last_update_submitted>
  <last_update_submitted_qc>January 24, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">January 27, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Abnormal pap test</keyword>
  <keyword>Sexual Dysfunction</keyword>
  <keyword>Epidemiology</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

